<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04595448</url>
  </required_header>
  <id_info>
    <org_study_id>1-10-72-113-20</org_study_id>
    <nct_id>NCT04595448</nct_id>
  </id_info>
  <brief_title>Lymphatic Function in Patients With Secondary Tricuspid Valve Regurgitation</brief_title>
  <acronym>LYMTRIVA</acronym>
  <official_title>Lymphatic Function in Patients With Secondary Tricuspid Valve Regurgitation - An Unknown Collaborator in a System Under Pressure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will examine the lymphatic functional and morphological status in patients with&#xD;
      moderate tricuspid valve regurgitation compared to healthy age and gender-matched controls.&#xD;
&#xD;
      The study will use t2 weighted MRI, Near-infrared fluorescence imaging, and plethysmography&#xD;
      to examine the above-mentioned question.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will examine the lymphatic functional and morphological status in patients with&#xD;
      moderate tricuspid valve regurgitation compared to healthy age and gender-matched controls.&#xD;
&#xD;
      Subjects will be examined at one occasion using t2-weighted MRIs to evaluated lymphatic&#xD;
      anatomy and Near-infrared fluorescence imaging for evaluation of superficial peripheral&#xD;
      lymphatic function. Finally, the capillary filtration rate will be estimated using&#xD;
      plethysmography.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 15, 2020</start_date>
  <completion_date type="Anticipated">September 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Thoracic duct tortuosity (centimeters/centimeters)</measure>
    <time_frame>20 minutes</time_frame>
    <description>Based on MRI, the thoracic duct will be rendered and measured with regards to tortuosity (full length/straight length)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thoracic duct volume (cubic centimetres)</measure>
    <time_frame>30 minutes</time_frame>
    <description>Based on MRI, the thoracic duct will be rendered and measured with regards to volume.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Excess fluid (yes/no)</measure>
    <time_frame>40 minutes</time_frame>
    <description>Based on MRI, the existence of excess fluid in the pericardial, thoracic and abdominal cavity will be accessed.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peripheral lymphatic velocity (centimeters/second)</measure>
    <time_frame>1 hour</time_frame>
    <description>Peripheral lymphatic fluid velocity (centimeters/second) will be calculated based upon NIRF sequences.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Peripheral lymphatic frequency (contractions/minute)</measure>
    <time_frame>1 hour 30 minutes</time_frame>
    <description>Peripheral lymphatic contraction frequency (contractions/minute) will be calculated based upon NIRF sequences.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Capillary filtration</measure>
    <time_frame>2 hours</time_frame>
    <description>Evaluation of capillary filtration rate estimated using plethysmography</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Lymphatic Insufficiency</condition>
  <condition>Heart Failure</condition>
  <condition>Edema</condition>
  <arm_group>
    <arm_group_label>Patients</arm_group_label>
    <description>Patients suffering from moderate tricuspid valve regurgitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Cardiovascular healthy, age, gender and weight matched controls.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with moderate to severe tricuspid regurgitation and healthy, age, gender, and&#xD;
        weight-matched controls&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Patients:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          -  Patients with moderate to severe tricuspid regurgitation&#xD;
&#xD;
          -  Age ≥18 years&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Reduced ejection fraction (&lt;50%)&#xD;
&#xD;
          -  Congenital heart disease&#xD;
&#xD;
          -  Left sided valve disease&#xD;
&#xD;
          -  MRI contraindications (All metal implants, cochlear implants, pacemakers etc.)&#xD;
&#xD;
          -  Claustrophobia&#xD;
&#xD;
          -  Peripheral edema&#xD;
&#xD;
          -  BMI&gt;30&#xD;
&#xD;
          -  Age&lt;18.&#xD;
&#xD;
        Controls:&#xD;
&#xD;
        Inclusion criteria:&#xD;
&#xD;
          -  Healthy&#xD;
&#xD;
          -  Age ≥18 years&#xD;
&#xD;
          -  Age, gender and weight matched with included patients.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Cardiovascular disease&#xD;
&#xD;
          -  MRI contraindications (All metal implants, cochlear implants, pacemakers etc.)&#xD;
&#xD;
          -  Claustrophobia&#xD;
&#xD;
          -  Peripheral edema&#xD;
&#xD;
          -  BMI&gt;30&#xD;
&#xD;
          -  Age&lt;18.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Benjamin Kelly, MD</last_name>
    <phone>+4560483488</phone>
    <email>benjaminkelly@clin.au.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Cardiothoracic Surgery</name>
      <address>
        <city>Aarhus N</city>
        <state>Central Denmark Region</state>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benjamin Kelly, MD</last_name>
      <phone>60483488</phone>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 18, 2020</study_first_submitted>
  <study_first_submitted_qc>October 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>April 27, 2021</last_update_submitted>
  <last_update_submitted_qc>April 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tricuspid Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

